Pabinafusp alfa Active Not Recruiting Phase 2 Trials for Mucopolysaccharidosis Type II (MPS II) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03708965An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II